A Closer Look at Democratic VP Choice Harris’s Positions on the 340B Program

A Message from Publisher and CEO Ted Slafsky: Please join us in welcoming AllianceRx Walgreens Prime as the newest 340B Report sponsor. We are very pleased to have them on board. For now, we have more requests for sponsorships than space

Read More »

Possibly Hundreds of Millions of Dollars Annually in Lost 340B Savings Draw Closer in California


A note from Publisher and CEO Ted Slafsky: Our sponsors are 340B’s industry leaders and we are proud to showcase their innovative solutions and guidance to help you implement and comply with this complex program. Click

Read More »

New York State Poised to Cut 340B Providers’ Medicaid Drug Reimbursement, Could Other States Follow?

Editor’s note: Share Your COVID-19 Stories With Us

340B health care providers: Are you experiencing drug shortages or other challenges fulfilling your mission during the COVID-19 emergency? We’d like to hear about what you’re up against and possibly share

Read More »

Update: 340B-Related Action in the States

Editors’ note: Have you read our 13-page special report on the 340B Coalition Winter Conference? We’ve received excellent feedback and think you and your colleagues will find it beneficial. Let us know what you think. Write to us at

Read More »

Think Tank to States: Use 340B to Reduce Drug Prices

Think Tank to States: Use 340B to Reduce Drug Prices

States should do more to help hospitals and other providers enroll in the 340B program as a way to lower drug prices, a liberal think tank with ties to the

Read More »

Vermont Bills Would Require 340B Hospitals to Report Drug Discount Savings and Spending

Vermont Bills Would Require 340B Hospitals to Report Drug Discount Savings and Spending

Companion bills filed this month in the Vermont House and Senate would require hospitals to report how much money they save through the 340B program

Read More »

Massachusetts Medicaid Wants to Stop Covering “High Cost” Drugs Bought Through 340B

(Editor’s note: The Medicare Payment Advisory Commission (MedPAC) tomorrow will consider a staff analysis of “whether the availability of 340B drug discounts creates incentives to choose more expensive products in some cases and the resulting impact on Medicare patients’ cost-share

Read More »

Breaking News

BREAKING: States Can Limit Providers’ Use of 340B Drugs for Medicaid Patients, CMS Says

BREAKING: States Can Limit Providers’ Use of 340B Drugs for Medicaid Patients, CMS Says

The Centers for Medicare & Medicaid Services released policy guidance yesterday outlining “best practices” states should consider for avoiding duplicate Medicaid rebates and 340B discounts

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live